Facebook
Twitter
Telegram
Report an ErrorVoyager Therapeutics Financial Statements 2011-2024 | VYGR
Annual Financial Statements Voyager Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
386 M | 282 M | 108 M | 280 M | 397 M | 337 M | 571 M | 295 M | 266 M | - | - | - | - |
Shares |
43 M | 38.4 M | 37.7 M | 37.1 M | 35.9 M | 32.1 M | 26.8 M | 25.3 M | 24.9 M | - | - | - | - |
Historical Prices |
8.98 | 7.36 | 2.86 | 7.55 | 11 | 10.5 | 20.6 | 11.9 | 10.7 | - | - | - | - |
Net Income |
132 M | -46.4 M | -71.2 M | 36.7 M | -43.6 M | -88.3 M | -70.7 M | -40.2 M | -29.7 M | -16.3 M | - | - | - |
Revenue |
250 M | 40.9 M | 37.4 M | 171 M | 104 M | 7.62 M | 10.1 M | 14.2 M | 17.3 M | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
122 M | -50.8 M | -73.6 M | 27.4 M | -51.7 M | -91.1 M | -71.9 M | -41.3 M | -20.3 M | -14.4 M | - | - | - |
Interest Expense |
3 K | 2.65 M | 2.81 M | 7.7 M | 1.62 M | -683 K | -62 K | 182 K | -9.75 M | -1.95 M | - | - | - |
EBITDA |
126 M | -44.6 M | -68.5 M | 31.2 M | -48.9 M | -89 M | -70.3 M | -40.7 M | -19.7 M | -14.2 M | - | - | - |
Operating Expenses |
128 M | 91.7 M | 111 M | 144 M | 156 M | 98.7 M | 82 M | 55.5 M | 37.6 M | - | - | - | - |
General and Administrative Expenses |
35.8 M | 31 M | 37.2 M | 35 M | 36.3 M | 33.8 M | 19.7 M | 13.3 M | 9.91 M | 5.47 M | - | - | - |
All numbers in USD currency
Quarterly Income Statement Voyager Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
57.1 M | 44 M | 43.9 M | 43.5 M | 40.6 M | 38.6 M | 38.5 M | 38.3 M | 38 M | 37.9 M | 37.8 M | 37.6 M | 37.5 M | 37.4 M | 37.2 M | 37 M | 37 M | 36.9 M | 36.7 M | 36.6 M | 33.4 M | 32.4 M | 32.2 M | 32 M | 31.8 M | 31.6 M | 26.2 M | 25.9 M | 25.8 M | 25.6 M | 25.4 M | 25.2 M | 25.1 M | 24.9 M | 1.32 M | 1.14 M | 1 M | 815 K | 684 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-11.3 M | - | -25.9 M | -22.2 M | 124 M | - | 17.6 M | -19.1 M | -21.3 M | - | -25.1 M | -30.1 M | -21.6 M | - | 85.6 M | -8.68 M | -24.3 M | -12.6 M | -15 M | 11.2 M | -27.2 M | -22.5 M | -20.3 M | -25.5 M | -19.9 M | -11.8 M | -23.3 M | -18.9 M | -16.6 M | -14.7 M | -9 M | -9.34 M | -7.19 M | -8.82 M | -3.92 M | -3.9 M | -14.6 M | -5.2 M | -4 M | -4.86 M | -3.21 M | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
19.5 M | - | 4.61 M | 4.85 M | 150 M | - | 41.1 M | 712 K | 658 K | - | 1.48 M | 1.36 M | 6.5 M | - | 118 M | 28.7 M | 18.1 M | 32.7 M | 20.4 M | 46.1 M | 5.2 M | 2.01 M | 2.09 M | 2.58 M | 942 K | 6.35 M | 1.15 M | 1.18 M | 1.46 M | 2.36 M | 3.31 M | 3.72 M | 4.83 M | 4.94 M | 4.94 M | 4.88 M | 2.58 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-16.2 M | - | -29.5 M | -25.4 M | 123 M | - | 14.4 M | -19.4 M | -21.4 M | - | -25.1 M | -28.6 M | -25.6 M | - | 84.5 M | -8.98 M | -24.4 M | -13.8 M | -17.8 M | 9.19 M | -29.3 M | -23.2 M | -21.1 M | -25.7 M | -21.1 M | -12.3 M | -23.4 M | -18.6 M | -17.5 M | -13.8 M | -10.4 M | -9.62 M | -7.47 M | -7.44 M | -4.02 M | -3.97 M | -4.83 M | -4.5 M | -3.66 M | -3.23 M | -2.98 M | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | 3 K | - | - | 2.64 M | 61 K | - | - | -112 K | -1.58 M | 3.92 M | - | 830 K | -46 K | -808 K | - | 978 K | -133 K | 978 K | - | -84 K | -717 K | 399 K | - | -282 K | -297 K | 395 K | - | -99 K | -150 K | -186 K | - | -9.75 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-15 M | - | - | - | 124 M | - | 19.8 M | -19.4 M | -18.5 M | - | -21.5 M | -28.6 M | -24.3 M | - | 87.4 M | -7.21 M | -23.6 M | -13.8 M | -15.8 M | 10.5 M | -28.7 M | -23.2 M | -19.6 M | -24.7 M | -20.6 M | -12.3 M | -22.2 M | -17.9 M | -17.2 M | -13.8 M | -9.92 M | -9.33 M | -7.33 M | -7.44 M | -3.96 M | -3.69 M | -4.7 M | -4.5 M | -3.5 M | -3.23 M | -2.98 M | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
35.7 M | - | 34.1 M | 30.3 M | 27.6 M | - | 26.6 M | 20.1 M | 22 M | - | 26.6 M | 29.9 M | 32.1 M | - | 33.3 M | 37.7 M | 42.5 M | 46.4 M | 38.2 M | 36.9 M | 34.5 M | 25.2 M | 23.2 M | 28.3 M | 22 M | 18.7 M | 24.5 M | 19.8 M | 19 M | 16.2 M | 13.7 M | 13.3 M | 12.3 M | 12.4 M | 8.96 M | 8.85 M | 7.4 M | 4.5 M | 3.66 M | 3.23 M | 2.98 M | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
8.61 M | - | 8.26 M | 8.29 M | 9.03 M | - | 7.31 M | 7.55 M | 7.66 M | - | 8.71 M | 10.4 M | 9.74 M | - | 8.28 M | 8.24 M | 10.2 M | - | 8.46 M | 8.32 M | 9.66 M | - | 6.61 M | 11.8 M | 7.18 M | - | 4.94 M | 4.52 M | 4.91 M | - | 3.37 M | 2.85 M | 3.56 M | - | 2.48 M | 2.4 M | 1.88 M | - | 1.26 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency